Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status

por Chao, Min-Wu, Chang, Li-Hsun, Tu, Huang-Ju, Chang, Chao-Di, Lai, Mei-Jung, Chen, Yi-Ying, Liou, Jing-Ping, Teng, Che-Ming, Pan, Shiow-Lin
Publicado 2019

A Novel Selective JAK2 Inhibitor Identified Using Pharmacological Interactions

por Lin, Tony Eight, HuangFu, Wei-Chun, Chao, Min-Wu, Sung, Tzu-Ying, Chang, Chao-Di, Chen, Yi-Ying, Hsieh, Jui-Hua, Tu, Huang-Ju, Huang, Han-Li, Pan, Shiow-Lin, Hsu, Kai-Cheng
Publicado 2018

In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer

por Chang, Chao-Di, Chao, Min-Wu, Lee, Hsueh-Yun, Liu, Yi-Ting, Tu, Huang-Ju, Lien, Ssu-Ting, Lin, Tony Eight, Sung, Tzu-Ying, Yen, Shih-Chung, Huang, Sing-Han, Hsu, Kai-Cheng, Pan, Shiow-Lin
Publicado 2023

Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach

por Chao, Min-Wu, Lin, Tony Eight, HuangFu, Wei-Chun, Chang, Chao-Di, Tu, Huang-Ju, Chen, Liang-Chieh, Yen, Shih-Chung, Sung, Tzu-Ying, Huang, Wei-Jan, Yang, Chia-Ron, Pan, Shiow-Lin, Hsu, Kai-Cheng
Publicado 2020